Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257881
Status:
TERMINATED
Last Update Posted:
2007-12-10
First Post:
2005-11-22
Brief Title:
Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization Data
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Class:
INDUSTRY
Study ID:
3152K1-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None